Device Trial Radar · NCT06750536
Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure
Last checked: Nov 20, 2026Latest source record: Dec 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Oct 12, 2025
Primary completion
Oct 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Xenios AGNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Alcedis GmbH
- First posted
- Dec 27, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, up to 8 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This prospective observational study will evaluate the safety and performance of the MiniLung petite kit in neonatal and pediatric patients with acute respiratory and cardiac failure. The main question it aims to answer is (study hypotheses): Veno-venous (VV) and veno-arterial (VA) Extracorporeal Membrane Oxygenation (ECMO) using the MiniLung petite kit is safe and improves gas exchange (oxygenation and CO2 removal) and hemodynamic stabilization in neonatal and pediatric patients with severe acute respiratory and/or cardiopulmonary failure within 24 hours compared to the treatment before VV or VA ECMO initiation and maintain a life-sustaining condition.
Conditions
- Extracorporeal Membrane Oxygenation Complication
- Neonatal Aspiration Pneumonia
- Acute Respiratory Failure
- Acute Lung Injury
Interventions
MiniLung petite kit combined with the Xenios consoleDevice
Veno-venous (VV) and veno-arterial (VA) Extracorporeal Membrane Oxygenation (ECMO) treatment will be performed using the MiniLung petite kit combined with the Xenios console according to their intended use and local standards/requirements.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Oxygenation IndexTime frame: Baseline and during the intervention every 24 hours until a maximum of 29 days
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Universitätsklinikum Mannheim
Mannheim, Germany · Recruiting
Universitätsklinkum Bonn
Bonn, North Rhine-Westphalia, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.